Kyle B. Peterson - 29 Mar 2023 Form 4 Insider Report for Signify Health, Inc.

Role
Director
Signature
/s/ Adam McAnaney, as attorney-in-fact for Kyle B. Peterson
Issuer symbol
N/A
Transactions as of
29 Mar 2023
Net transactions value
$0
Form type
4
Filing time
29 Mar 2023, 08:51:58 UTC
Previous filing
23 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGFY Class A Common Stock Disposed to Issuer -14,672 -100% 0 29 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kyle B. Peterson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.